CENTESSA PHARMACEUTICALS-ADR (CNTA) Institutional Ownership Changes & 13F Activity
CENTESSA PHARMACEUTICALS-ADR (CNTA) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | Renaissance Technologies LLC | Sell | -94,300 | 185,000 | $7,348,200 |
| Q4 2025 | Renaissance Technologies LLC | Buy | 114,700 | 279,300 | $6,985,293 |
| Q3 2025 | Renaissance Technologies LLC | Sell | -220,300 | 164,600 | $3,991,550 |
| Q2 2025 | Renaissance Technologies LLC | Buy | 206,900 | 384,900 | $5,057,586 |
| Q1 2025 | Renaissance Technologies LLC | Sell | -600 | 178,000 | $2,559,640 |
| Q4 2024 | Renaissance Technologies LLC | Sell | -31,000 | 178,600 | $2,991,550 |
| Q3 2024 | Renaissance Technologies LLC | Buy | 35,900 | 209,600 | $3,351,504 |
| Q2 2024 | Renaissance Technologies LLC | Sell | -45,100 | 173,700 | $1,568,511 |
| Q1 2024 | Renaissance Technologies LLC | Buy | 33,200 | 218,800 | $2,472 |
| Q4 2023 | Renaissance Technologies LLC | Buy | 132,500 | 185,600 | $1,477 |
| Q3 2023 | Renaissance Technologies LLC | Buy | 18,800 | 53,100 | $344 |
| Q2 2023 | Renaissance Technologies LLC | Buy | 18,600 | 34,300 | $212 |
| Q1 2023 | Renaissance Technologies LLC | Buy | 15,700 | 15,700 | $60 |
Frequently asked questions about CNTA activity
Which institutional owners are buying CNTA?
Institutional owners buying CNTA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CNTA activity?
"Buy" means an investor increased their reported position in CNTA compared to the prior reporting period. This reflects growing exposure to CENTESSA PHARMACEUTICALS-ADR (CNTA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CNTA increasing?
Institutional interest in CNTA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CNTA insights
- CNTA Overview
- CNTA Institutions
- CNTA Institutional Ownership
- CNTA Top Shareholders
- CNTA Institutional Buying
- CNTA Institutional Selling
- CNTA Ownership Changes
- CNTA Insiders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Owners in Q1 2026
- Most Sold Healthcare Stocks By Institutional Owners in Q1 2026
- Top Institutional Investor Stock Rankings